JOHN WATES: Open Payments
NPI 1639284938 · EDGEFIELD, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$407 in 21 payments from 13 companies in 2025. Trend: 2023 $845 · 2024 $394 · 2025 $407
Food & beverage: $407
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $64 |
| ABBVIE INC. | 2 | $54 |
| Exact Sciences Corporation | 2 | $38 |
| Abbott Laboratories | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| Novo Nordisk Inc | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $31 |
| Dexcom, Inc. | 1 | $26 |
| PFIZER INC. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $18 |
Products named: VRAYLAR, AIRSUPRA, The Cologuard Plus Collection Kit, LEQVIO, Ozempic, REXULTI, Dexcom G6 Transmitter, ELIQUIS.
Industry payments across SC — which companies pay providers there.
